Myriad Genetics Inc (MYGN)

EBITDA Margin

-5.60%

TTM · Period ending:

MYGN logo

MYGN EBITDA Margin

Latest reported-5.60%
MYGN EBITDA Margin (-110.61% → -5.60%)
High-resolution chart · PNG

MYGN ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-40.1334%
-7.1036%
-26.2082%
-12.4853%
1.7811%
-22.1544%
-22.0013%
9.9871%
23.894%
12.4194%
24.7265%
22.1408%
37.0342%
38.6334%
38.1825%
41.0355%
39.2003%
41.6232%
31.5838%
-25.5737%
-33.8942%
-42.0515%
-65.0844%
-34.3138%
-26.3086%
-20.8314%
-24.2918%
-36.3636%
-41.8103%
-65.7895%
-110.6061%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.